Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Gastroenterology. 2010 Jun 9;139(3):836–845.e1. doi: 10.1053/j.gastro.2010.06.009

Table 4.

Genotype-phenotype association between ADRB2 (beta-2 adrenergic receptor) polymorphisms and gamma-glutamyl transpeptidase in twins.

SNP domain Diploid
genotype
code
Gamma-glutamyl
transpeptidase, IU/L
Diploid
genotype
bases
N P value

Mean SEM

Promoter G-1023A 1 18.2 1.4 G/G 109 0.025
(rs2053044) 2 23.3 1.7 G/A 136
3 24.9 3.3 A/A 80

Promoter C-468G 1 19.4 1.1 C/C 106 0.015
(rs11168070) 2, 3 24.7 1.9 C/G or G/G 221

Promoter T-367C 1 19.6 1.1 T/T 112 0.021
(rs11959427) 2, 3 24.7 2.0 T/C or C/C 219

Promoter T-47C 1 19.5 1.1 T/T 117 0.012
(rs1042711) 2, 3 24.8 1.9 T/C or C/C 213

Glu27Gln, G298C 1 19.5 1.1 C/C 104 0.016
(rs1042714) 2, 3 24.8 1.9 C/G or G/G 224

Footnote:

This table shows that five SNPs in the beta-2-adrenergic receptor gene (ADRB2) predict with plasma GGT, a marker of fatty liver. SNP statistics for twin study population are derived from generalized estimating equations (GEEs; PROC GENMOD) in SAS, version 9.1 (SAS Institute, Cary, NC) to account for correlations within twinships. Results are displayed for trait (plasma GGT) mean (IU/L, ± one SEM). All analyses are adjusted for age and sex. GGT was treated as a continuous outcome variable. A two-tailed p-value of ≤0.05 was considered statistically significant.